634 related articles for article (PubMed ID: 30149876)
21. High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor.
Okazawa Y; Mizukoshi K; Koyama Y; Okubo S; Komiyama H; Kojima Y; Goto M; Habu S; Hino O; Sakamoto K; Orimo A
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985333
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Maccalli C; Parmiani G; Ferrone S
Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
[TBL] [Abstract][Full Text] [Related]
23. The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents.
Morillon YM; Sabzevari A; Schlom J; Greiner JW
Anticancer Res; 2020 Oct; 40(10):5329-5341. PubMed ID: 32988851
[TBL] [Abstract][Full Text] [Related]
24. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
25. A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research.
Li Z; Yang X; Zhang Y; Yang X; Cui X; Zhang Y; Gong W; Bai H; Liu N; Tang Z; Guo M; Li K; Zhang T; Wang L; Song X
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475974
[TBL] [Abstract][Full Text] [Related]
26. Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors.
Lanis JM; Lewis MS; Strassburger H; Larsen K; Bagby SM; Dominguez ATA; Marín-Jiménez JA; Pelanda R; Pitts TM; Lang J
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591990
[TBL] [Abstract][Full Text] [Related]
27. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
[TBL] [Abstract][Full Text] [Related]
28. Humanized Mouse Models for Immuno-oncology Drug Discovery.
Kumari R; Feuer G; Bourré L
Curr Protoc; 2023 Aug; 3(8):e852. PubMed ID: 37552031
[TBL] [Abstract][Full Text] [Related]
29. A mouse model for evaluation of efficacy and concomitant toxicity of anti-human CXCR4 therapeutics.
Costa MJ; Kudaravalli J; Liu WH; Stock J; Kong S; Liu SH
PLoS One; 2018; 13(3):e0194688. PubMed ID: 29554149
[TBL] [Abstract][Full Text] [Related]
30. [At the crossroads of cancer].
Chouaib S
Bull Cancer; 2013 Jun; 100(6):569-74. PubMed ID: 23735599
[TBL] [Abstract][Full Text] [Related]
31. Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology.
Saito R; Kobayashi T; Kashima S; Matsumoto K; Ogawa O
Int J Clin Oncol; 2020 May; 25(5):831-841. PubMed ID: 31407168
[TBL] [Abstract][Full Text] [Related]
32. Patient-Derived Xenograft Models of Breast Cancer and Their Application.
Murayama T; Gotoh N
Cells; 2019 Jun; 8(6):. PubMed ID: 31226846
[TBL] [Abstract][Full Text] [Related]
33. Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice.
Sanmamed MF; Rodriguez I; Schalper KA; Oñate C; Azpilikueta A; Rodriguez-Ruiz ME; Morales-Kastresana A; Labiano S; Pérez-Gracia JL; Martín-Algarra S; Alfaro C; Mazzolini G; Sarno F; Hidalgo M; Korman AJ; Jure-Kunkel M; Melero I
Cancer Res; 2015 Sep; 75(17):3466-78. PubMed ID: 26113085
[TBL] [Abstract][Full Text] [Related]
34. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.
Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP
Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081
[TBL] [Abstract][Full Text] [Related]
35. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
Jung J; Seol HS; Chang S
Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
[TBL] [Abstract][Full Text] [Related]
36. [Tumor immunology (author's transl)].
Barandun S; Morell A
Pathol Microbiol (Basel); 1975; 42(4):302-11. PubMed ID: 778765
[TBL] [Abstract][Full Text] [Related]
37. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
38. Subrenal capsule grafting technology in human cancer modeling and translational cancer research.
Wang Y; Wang JX; Xue H; Lin D; Dong X; Gout PW; Gao X; Pang J
Differentiation; 2016; 91(4-5):15-9. PubMed ID: 26547391
[TBL] [Abstract][Full Text] [Related]
39. Construction of a Humanized PBMC-PDX Model to Study the Efficacy of a Bacterial Marker in Lung Cancer Immunotherapy.
Wu C; Wang X; Shang H; Wei H
Dis Markers; 2022; 2022():1479246. PubMed ID: 36072895
[TBL] [Abstract][Full Text] [Related]
40. Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract.
Damhofer H; Ebbing EA; Steins A; Welling L; Tol JA; Krishnadath KK; van Leusden T; van de Vijver MJ; Besselink MG; Busch OR; van Berge Henegouwen MI; van Delden O; Meijer SL; Dijk F; Medema JP; van Laarhoven HW; Bijlsma MF
J Transl Med; 2015 Apr; 13():115. PubMed ID: 25884700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
